Substrate
Topic

medical innovation

4 stories related to this topic, newest first.

Hong Kong Researchers Develop Nasal Spray for Stroke Aid, Wins Geneva Invention PrizeBaycrest / Wikimedia (CC BY-SA 2.5)
world1 day agoDeveloping

Hong Kong Researchers Develop Nasal Spray for Stroke Aid, Wins Geneva Invention Prize

Researchers at the University of Hong Kong have created a nasal spray that delivers neurotherapeutic powder to the brain for ischemic stroke patients. The innovation, called NanoPowder, won the Special Grand Prize and a gold medal at the 51st International Exhibition of Invention…

South China Morning Post
1 source
world10 days agoDeveloping

Doctors Test Mobile Brain Scanners in Australia's Outback for Rapid Stroke Diagnosis

Doctors in Australia's outback are testing mobile brain scanners capable of distinguishing clots from bleeds. These devices provide results in minutes. The testing aims to improve stroke care in remote areas.

Bloomberg
1 source
California Snakebite Deaths Highlight Development of Oral Antivenom TreatmentSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
world10 days agoDeveloping

California Snakebite Deaths Highlight Development of Oral Antivenom Treatment

Recent snakebite fatalities in California have drawn attention to efforts to develop an oral antivenom pill. Ophirex is advancing Varespladib, a treatment designed to improve survival odds after bites from common U.S. snakes. The pill is intended for immediate use before hospital…

Los Angeles Times
1 source
CAR-T Therapy Shows Increasing Remissions in Autoimmune Diseases with Rising Experimentation and InvestmentSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
science26 days ago

CAR-T Therapy Shows Increasing Remissions in Autoimmune Diseases with Rising Experimentation and Investment

CAR-T cell therapy, originally developed for cancer treatment, is achieving more remissions in patients with autoimmune diseases. According to STAT News, this progress has prompted additional clinical trials and investments from pharmaceutical companies.

ST
1 source